Parla
Provides easy at-home fertility tests, a science based plan and access to leading experts.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor investor | €0.0 | round |
| investor investor | €0.0 | round | |
N/A | Grant | ||
| Total Funding | 000k | ||
| USD | 2022 | 2023 |
|---|---|---|
| Revenues | 0000 | 0000 |
| % growth | - | 33 % |
| EBITDA | 0000 | 0000 |
| Profit | 0000 | 0000 |
| EV | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Parla operates as a digital health platform focused on women's reproductive health, aiming to provide proactive, personalized, and holistic support. The company was founded in 2018 by Lina Chan, her husband Tyler Christie, and Rose Acton. Chan's personal experiences with pregnancy loss and difficulties in conceiving served as the primary catalyst for the venture. Before becoming an entrepreneur, she had a career spanning over 15 years as a private equity investor in the U.S. and the U.K., with an MBA from The Wharton School. This background in finance and her personal journey through reproductive challenges shaped the company's mission to address the gaps she perceived in women's healthcare.
The company's core business revolves around a virtual support system designed to improve women's mental and physical wellness related to reproductive health issues. It targets a range of challenges including PCOS, endometriosis, and pregnancy loss. Parla's model utilizes cohort-based online learning programs that connect women with similar experiences to a network of experts in fertility, psychology, nutrition, and wellbeing. This approach combines expert coaching with peer support to tackle sensitive health topics. In addition to community and expert access, the platform offers at-home hormone testing, health quizzes, and personalized health insights, supported by an app. The business aims to empower women with knowledge and break the taboos surrounding these health issues.
In June 2022, Parla was acquired by Holland & Barrett, a major European health and wellness retailer. This acquisition is part of Holland & Barrett's strategy to expand beyond retail into personalized wellness services. Lina Chan continues to lead Parla within the larger organization, with the goal of integrating and expanding women's health services. The acquisition provides Parla with a larger platform to pursue its mission of making discussions around women's health more mainstream and accessible.
Keywords: women's health, femtech, fertility support, reproductive health, digital health platform, peer support, health education, pregnancy loss, endometriosis, cohort-based learning